uniQure N.V. Earnings Per Share, Basic and Diluted
uniQure N.V. (QURE) reported Earnings Per Share, Basic and Diluted of -$0.91 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-10
- uniQure N.V. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.91.
- uniQure N.V. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.02.
- uniQure N.V. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$1.21.
- uniQure N.V. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.96.
- uniQure N.V. earnings per share, basic and diluted for fiscal 2020 was -$2810.00.
- uniQure N.V. earnings per share, basic and diluted for fiscal 2019 was -$3110.00.
- uniQure N.V. earnings per share, basic and diluted for fiscal 2018 was -$2340.00.
- uniQure N.V. earnings per share, basic and diluted for fiscal 2017 was -$2940.00.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | -$0.91 10-Q · filed 2021-05-10 | -$0.94 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$2.14 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$3.10 derived: net income ÷ weighted average shares · filed 2023-02-27 | |||
| 2020-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$1.22 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$2.18 derived: net income ÷ weighted average shares · filed 2023-02-27 | -$2810.00 10-K · filed 2021-03-01 | |||
| 2020-09-30 | -$1.21 10-Q · filed 2020-10-27 | -$2.17 derived: net income ÷ weighted average shares · filed 2021-10-25 | -$2.80 10-Q · filed 2020-10-27 | -$3.75 derived: net income ÷ weighted average shares · filed 2022-02-25 | |||
| 2020-06-30 | -$0.96 10-Q · filed 2020-07-30 | -$1.59 10-Q · filed 2020-07-30 | -$2.54 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$3.13 derived: net income ÷ weighted average shares · filed 2022-02-25 | |||
| 2020-03-31 | -$0.63 10-Q · filed 2021-05-10 | -$1.58 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$2.17 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$2.99 derived: net income ÷ weighted average shares · filed 2022-02-25 | |||
| 2019-12-31 | -$0.95 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$1.54 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$2.37 derived: net income ÷ weighted average shares · filed 2022-02-25 | -$3110.00 10-K · filed 2021-03-01 | |||
| 2019-09-30 | -$0.58 10-Q · filed 2020-10-27 | -$1.40 derived: net income ÷ weighted average shares · filed 2020-10-27 | -$2.14 10-Q · filed 2020-10-27 | -$2.73 derived: net income ÷ weighted average shares · filed 2021-03-01 | |||
| 2019-06-30 | -$0.83 10-Q · filed 2020-07-30 | -$830.00 10-Q · filed 2019-07-29 | -$1.57 10-Q · filed 2020-07-30 | -$1570.00 10-Q · filed 2019-07-29 | -$2.16 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$2.75 derived: net income ÷ weighted average shares · filed 2021-03-01 | |
| 2019-03-31 | -$0.74 10-Q · filed 2020-04-29 | -$740.00 10-Q · filed 2019-04-29 | -$1.32 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$1.92 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$2.49 derived: net income ÷ weighted average shares · filed 2021-03-01 | ||
| 2018-12-31 | -$0.59 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$1.18 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$1.75 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$2340.00 10-K · filed 2021-03-01 | -$2.34 10-K · filed 2019-02-28 | ||
| 2018-09-30 | -$0.59 10-Q · filed 2019-10-28 | -$1.16 derived: net income ÷ weighted average shares · filed 2019-10-28 | -$1.75 10-Q · filed 2019-10-28 | -$2.61 derived: net income ÷ weighted average shares · filed 2020-03-02 | |||
| 2018-06-30 | -$570.00 10-Q · filed 2019-07-29 | -$0.57 10-Q · filed 2018-08-08 | -$1160.00 10-Q · filed 2019-07-29 | -$1.16 10-Q · filed 2018-08-08 | -$2.02 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$2.47 derived: net income ÷ weighted average shares · filed 2020-03-02 | |
| 2018-03-31 | -$590.00 10-Q · filed 2019-04-29 | -$0.59 10-Q · filed 2018-04-30 | -$1.47 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$1.91 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$2.72 derived: net income ÷ weighted average shares · filed 2020-03-02 | ||
| 2017-12-31 | -$0.88 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$1.33 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$2.15 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$2940.00 10-K · filed 2020-03-02 | -$2.94 10-K · filed 2018-03-14 | ||
| 2017-09-30 | -$0.40 10-Q · filed 2018-11-06 | -$1.23 derived: net income ÷ weighted average shares · filed 2018-11-06 | -$2.03 10-Q · filed 2018-11-06 | -$2.61 derived: net income ÷ weighted average shares · filed 2019-02-28 | |||
| 2017-06-30 | -$0.83 10-Q · filed 2018-08-08 | -$1.63 10-Q · filed 2018-08-08 | -$2.21 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.82 derived: net income ÷ weighted average shares · filed 2019-02-28 | |||
| 2017-03-31 | -$0.80 10-Q · filed 2018-04-30 | -$1.38 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.99 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.83 derived: net income ÷ weighted average shares · filed 2019-02-28 | |||
| 2016-12-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.19 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.03 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$2.93 10-K · filed 2019-02-28 | |||
| 2016-09-30 | -$0.61 10-Q · filed 2017-11-01 | -$1.45 derived: net income ÷ weighted average shares · filed 2017-11-01 | -$2.35 10-Q · filed 2017-11-01 | ||||
| 2016-06-30 | -$0.84 10-Q · filed 2017-08-08 | -$1.74 10-Q · filed 2017-08-08 | |||||
| 2016-03-31 | -$0.90 10-Q · filed 2017-05-09 | ||||||
| 2015-12-31 | -$3.72 10-K · filed 2018-03-14 | ||||||
| 2014-12-31 | -$2.91 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |